1 ert-butylcalix[4]arene tetraethyl ester, and calcimycin.

2 hartreusins, cephalosporins, holomycins, and calcimycin.

3 s caffeine and 4-chloro-3-ethylphenol (CEP), calcimycin (a Ca2+ ionophore) and carbonyl cyanide m-chl

4 ified lipid stores by calcium ionophore (CI) calcimycin (A-23187).

5             Treatment of N/N1003A cells with calcimycin, a calcium mobilizer, activates the RAF/MEK/E

6 compared with two established Mn ionophores, calcimycin (A23187) and ionomycin.

7  EPS with the pharmacological Ca(2+) carrier calcimycin (A23187) because contraction induces marked i

8                                              Calcimycin also activates p38 kinase and JNK2, which are

9 erated by raising intracellular Ca(2+) using calcimycin, and increased AR breakdown was reversed with

10                           Caffeine, CEP, and calcimycin increased resting [Ca2+]i to a greater extent

11     Moreover, overexpression of p53 enhances calcimycin-induced apoptosis, whereas inhibition of p53

12 reas inhibition of p53 expression attenuates calcimycin-induced apoptosis.

13 it ERK1/2 activation, and greatly attenuates calcimycin-induced apoptosis.

14 -cultured rat lenses, the peptides inhibited calcimycin-induced epithelial cell apoptosis.

15 e, but intact cells showed no differences in calcimycin-induced onset of mPT, irrespective of energiz

16                          The wild-type-like, calcimycin-induced response in csp null mutants indicate

17                     De-energization hastened calcimycin-induced swelling in control and partially-exp

18         Activation of RAF/MEK/ERK pathway by calcimycin leads to distinct up-regulation of p53.

19 )-stimulated increases in IL-6 mRNA, neither calcimycin- nor EPS-induced IL-6 mRNA expression is unde

20 mPT's voltage-sensing properties elicited by calcimycin or H2O2 in human fibroblasts exhibiting parti

21 scovered that BWSV and the calcium ionophore calcimycin stimulate FM1-43 destaining and quantal relea

22  inhibited phorbol myristate acetate (PMA) + calcimycin-stimulated IFN-gamma and IL-2 (but not IL-13)